Jiangsu Bioperfectus Technologies Co., Ltd. - Laporan Laba Rugi (TTM)

Jiangsu Bioperfectus Technologies Co., Ltd.
CN ˙ SHSE
CN¥ 65.52 ↑0.89 (1.38%)
2025-09-08
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Jiangsu Bioperfectus Technologies Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,199 1,740 2,396 2,298 2,811 2,839 3,504 4,974 4,961 5,535 4,107 2,455 1,518 403 400 394 395 350 350 348
Change (%) 45.11 37.72 -4.10 22.34 1.00 23.44 41.95 -0.28 11.57 -25.80 -40.21 -38.19 -73.44 -0.73 -1.56 0.21 -11.45 0.14 -0.67
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 226 391 593 599 795 880 1,204 1,891 1,957 2,380 1,863 1,155 802 254 248 226 236 148 160 162
Change (%) 72.73 51.74 1.11 32.66 10.66 36.86 57.03 3.47 21.64 -21.75 -37.98 -30.62 -68.32 -2.46 -8.71 4.26 -37.38 8.16 1.76
% of Revenue 18.87 22.46 24.75 26.09 28.29 31.00 34.37 38.02 39.45 43.00 45.35 47.05 52.81 62.98 61.89 57.39 59.71 42.23 45.61 46.73
Gross Operating Profit 973 1,349 1,803 1,698 2,016 1,959 2,300 3,083 3,004 3,155 2,244 1,300 716 149 153 168 159 202 190 185
Change (%) 38.69 33.66 -5.81 18.69 -2.81 17.41 34.05 -2.57 5.02 -28.85 -42.07 -44.91 -79.16 2.21 10.05 -5.25 26.97 -5.72 -2.71
% of Revenue 81.13 77.54 75.25 73.91 71.71 69.00 65.63 61.98 60.55 57.00 54.65 52.95 47.19 37.02 38.11 42.61 40.29 57.77 54.39 53.27
SG&A 229 373 486 490 536 547 592 738 705 779 629 493 513 407 386 350 280 178 178 187
Change (%) 62.62 30.51 0.84 9.37 2.03 8.18 24.69 -4.52 10.52 -19.23 -21.62 3.99 -20.64 -5.04 -9.52 -19.85 -36.55 0.15 5.10
% of Revenue 19.12 21.42 20.30 21.35 19.08 19.28 16.90 14.84 14.21 14.08 15.32 20.08 33.79 100.95 96.56 88.75 70.99 50.86 50.87 53.82
R&D 56 70 75 81 89 106 117 176 213 185 192 149 116 135 121 113 109 101 100 94
Change (%) 24.99 6.63 7.70 9.56 20.13 10.06 50.20 20.90 -12.81 3.85 -22.73 -21.98 16.70 -10.73 -6.21 -3.69 -7.92 -0.67 -5.56
% of Revenue 4.70 4.04 3.13 3.52 3.15 3.75 3.34 3.53 4.28 3.35 4.69 6.06 7.64 33.58 30.20 28.77 27.65 28.75 28.52 27.12
OpEx 507 829 1,148 1,164 1,416 1,528 1,913 2,812 2,880 3,362 2,690 1,786 1,417 787 729 674 573 419 451 457
Change (%) 63.48 38.52 1.43 21.66 7.90 25.19 46.99 2.39 16.75 -19.99 -33.60 -20.66 -44.43 -7.43 -7.55 -14.99 -26.93 7.68 1.49
% of Revenue 42.28 47.64 47.91 50.67 50.39 53.84 54.60 56.54 58.05 60.74 65.49 72.73 93.36 195.31 182.12 171.03 145.08 119.72 128.73 131.54
Operating Income 692 911 1,248 1,133 1,394 1,311 1,591 2,162 2,081 2,173 1,417 670 101 -384 -329 -280 -178 -69 -101 -110
Change (%) 31.66 36.99 -9.18 23.03 -6.01 21.39 35.89 -3.75 4.41 -34.78 -52.76 -84.95 -481.47 -14.46 -14.85 -36.40 -61.26 45.90 9.03
% of Revenue 57.72 52.36 52.09 49.33 49.61 46.16 45.40 43.46 41.95 39.26 34.51 27.27 6.64 -95.31 -82.12 -71.03 -45.08 -19.72 -28.73 -31.54
Interest Expense -0 -0 -1 -3 -4 -5 -7 -6 -5 -5 -5 -6 -7 -7 -7 -7 -8 -8 -9
Change (%) 436.61 66.94 244.11 54.62 30.57 33.67 -13.17 -11.24 2.06 -8.30 29.91 7.08 2.17 2.79 0.52 5.75 3.42 10.50
% of Revenue -0.00 -0.02 -0.03 -0.09 -0.14 -0.15 -0.14 -0.12 -0.10 -0.13 -0.20 -0.43 -1.72 -1.77 -1.85 -1.86 -2.22 -2.29 -2.55
Net Income 616 820 1,103 1,014 1,234 1,193 1,437 1,925 1,821 1,828 1,177 526 28 -374 -314 -276 -171 -2 -29 -27
Change (%) 33.09 34.63 -8.10 21.69 -3.30 20.42 33.95 -5.37 0.36 -35.59 -55.32 -94.77 -1,457.73 -15.91 -12.10 -38.22 -98.83 1,361.27 -6.84
% of Revenue 51.36 47.11 46.05 44.13 43.90 42.03 41.00 38.69 36.72 33.03 28.67 21.42 1.81 -92.72 -78.53 -70.12 -43.23 -0.57 -8.35 -7.84

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista